Core Viewpoint - The company, Boke Testing (301598), has established itself as a leading provider of intelligent testing solutions in China, focusing on hydraulic testing equipment and automotive testing devices, with a competitive edge over foreign brands [1] Company Overview - Boke Testing utilizes modern testing and experimental technologies to deliver comprehensive testing solutions [1] - The company is one of the few in China capable of mass-producing hydraulic testing equipment and automotive testing devices [1] Competitive Advantage - The company leverages its technological leadership, innovative research and development capabilities, project execution experience, and customer service strengths to build a strong market position [1] - Boke Testing has gained widespread recognition from clients due to its core advantages [1]

Core Viewpoint - The company, Boke Testing, provides servo testing equipment that is widely applicable in product research and development, reliability testing, and various structural tests, primarily serving the electronic information market [2] Summary by Categories Company Overview - Boke Testing specializes in servo testing equipment [2] - The company engages in various applications including product R&D, reliability testing, and structural testing [2] Market Application - The primary downstream market for the company's products includes electronic information [2]

Group 1 - On September 10, Boke Testing's stock rose by 3.70%, with a trading volume of 92.57 million yuan [1] - The financing data for Boke Testing on that day showed a financing purchase amount of 13.33 million yuan and a net financing purchase of 2.13 million yuan [1] - As of September 10, the total balance of margin trading for Boke Testing was 53.80 million yuan, accounting for 5.50% of its circulating market value [1] Group 2 - As of August 29, the number of shareholders for Boke Testing was 8,819, a decrease of 3.26% from the previous period [2] - For the first half of 2025, Boke Testing achieved an operating income of 241 million yuan, a year-on-year increase of 12.67%, and a net profit attributable to shareholders of 47.94 million yuan, up 16.65% year-on-year [2] - Since its A-share listing, Boke Testing has distributed a total of 76.57 million yuan in dividends [2]

Group 1 - The company, Boke Testing (301598), reported that as of August 20, 2025, the total number of shareholders (including both ordinary accounts and margin trading accounts) is 9,116 [1]

Group 1 - The company has not yet ventured into the field of robot testing [2] - The company will disclose any new information through the Shenzhen Stock Exchange website [2] - Investors are encouraged to refer to previously disclosed announcements for more industry information [2]

Group 1 - The core viewpoint of the news is that 博科测试 experienced a decline in stock price and had a negative net financing buy on August 29, 2023, indicating potential investor caution [1][2] - On August 29, 博科测试 had a financing buy amount of 8.68 million yuan and a financing repayment of 9.63 million yuan, resulting in a net financing buy of -0.95 million yuan [1][2] - As of August 29, the total financing and securities lending balance for 博科测试 was 65.38 million yuan, which represents 6.89% of its circulating market value [2] Group 2 - 博科测试's main business revenue composition includes 78.59% from automotive testing solutions, 20.71% from servo hydraulic testing solutions, and 0.70% from agency services [2] - For the first half of 2025, 博科测试 achieved an operating income of 241 million yuan, reflecting a year-on-year growth of 12.67%, and a net profit attributable to shareholders of 47.94 million yuan, up 16.65% year-on-year [2] - Since its A-share listing, 博科测试 has distributed a total of 76.57 million yuan in dividends [3]

Core Viewpoint - 博科测试 (301598) reported a solid performance in its 2025 mid-year financial results, with significant increases in revenue and net profit compared to the previous year [1] Financial Performance - The total revenue for the first half of 2025 reached 241 million yuan, marking a year-on-year increase of 12.67% [1] - The net profit attributable to shareholders was 47.94 million yuan, up 16.65% year-on-year [1] - In Q2 2025, the revenue was 153 million yuan, reflecting a 4.91% increase year-on-year, while the net profit was 33.84 million yuan, a 4.02% increase [1] Key Financial Metrics - Gross margin stood at 42.51%, a decrease of 4.53% year-on-year, while net margin improved to 19.85%, an increase of 3.53% [1] - Total expenses (selling, administrative, and financial) amounted to 32.02 million yuan, accounting for 13.26% of revenue, down 3.87% year-on-year [1] - Earnings per share (EPS) was 0.81 yuan, down 12.51% year-on-year, while the net asset per share increased by 55.77% to 16.3 yuan [1] Cash Flow and Receivables - The company reported a significant increase in accounts receivable, which rose by 100.34% year-on-year [1] - Operating cash flow per share was 1.28 yuan, a decrease of 15.4% compared to the previous year [1] Return on Investment - The company's return on invested capital (ROIC) for the previous year was 12.61%, indicating strong capital returns [3] - The historical median ROIC since the company went public is 36.6%, suggesting good investment returns over time [3] Financial Health Indicators - The company has a healthy cash asset position, with a cash flow to current liabilities ratio averaging 18.17% over the past three years [3] - Concerns were raised regarding the accounts receivable and inventory levels, with accounts receivable to profit ratio at 165.08% and inventory to revenue ratio at 110.21% [3]

Core Viewpoint - The company has proposed a profit distribution plan for the first half of 2025, aiming to reward shareholders while considering its overall development strategy and operational conditions [1][2]. Group 1: Profit Distribution Plan - The profit distribution plan is based on the net profit of CNY 47,938,680.26 for the first half of 2025, with a total distributable profit of CNY 111,325,675.00 available for shareholders [1]. - The company plans to distribute a cash dividend of CNY 7 per 10 shares, totaling CNY 41,228,056.10, with no stock dividends or capital reserve transfers [2]. - The plan is compliant with relevant laws and regulations, ensuring the protection of minority shareholders' rights and balancing short-term and long-term interests [2]. Group 2: Legal Compliance and Rationale - The profit distribution plan adheres to the Company Law, regulatory guidelines, and the company's articles of association, reflecting a comprehensive consideration of the company's current performance and future funding needs [2]. - The proposal aims to allow all shareholders to share in the company's operational success, demonstrating its legality, compliance, and reasonableness [2].

北京博科测试系统股份有限公司 关联方资金往来管理制度 第一章 总则 第一条 为了加强和规范北京博科测试系统股份有限公司（以下简称公司）的资金 管理，防止和杜绝公司关联方占用公司资金行为的发生，保护公司、股东和其他利益相 关人的合法权益，根据《中华人民共和国公司法》（以下简称《公司法》）、《中华人 民共和国证券法》（以下简称《证券法》）《上市公司监管指引第 8 号——上市公司资 金往来、对外担保的监管要求》《深圳证券交易所创业板股票上市规则》《深圳证券交 易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》及《北京博科测试系 统股份有限公司章程》（以下简称《公司章程》）的有关规定，结合公司实际，制定本 制度。 第二条 本制度适用于公司关联方与公司之间的资金管理。纳入公司合并会计报表 范围的子公司适用本制度，公司关联方与纳入合并会计报表范围的子公司之间的资金往 来，参照本制度执行。 第三条 本制度所称"关联方"，是指根据相关法律、法规和《深圳证券交易所创 业板股票上市规则》所界定的关联方，包括关联法人和关联自然人。 第四条 本制度所称"占用上市公司资金"（以下称资金占用），包括：经营性资 金占用和非经营 ...

北京博科测试系统股份有限公司 募集资金管理办法 第一章 总则 第一条 为了加强北京博科测试系统股份有限公司（以下简称公司）募集资 金行为的管理，规范募集资金的使用，切实保护广大投资者的利益，根据《中华 人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证券法》（以 下简称《证券法》）、《上市公司募集资金监管规则》（下称《监管规则》）、 《深圳证券交易所创业板股票上市规则》（以下简称《股票上市规则》）、《深 圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》（以 下简称《规范运作指引》）等有关法律、法规、规章、规范性文件和《北京博科 测试系统股份有限公司章程》（以下简称《公司章程》）的有关规定，制定本办 法。 第二条 本办法所称募集资金是指公司通过发行股票及其衍生品种，向投资 者募集并用于特定用途的资金，但不包括上市公司实施股权激励计划募集的资金。 第三条 公司的董事、高级管理人员应当勤勉尽责，督促公司规范使用募集 资金，自觉维护公司募集资金安全，不得参与、协助或纵容公司擅自或变相改变 募集资金用途。 第四条 公司控股股东、实际控制人不得直接或者间接占用或者挪用公司募 集资金，不得利 ...